欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号PT/H/1195/001
药品名称Linezolida Combino
活性成分
    • linezolid 2.0 mg/ml
剂型Solution for infusion
上市许可持有人Combino Pharm Portugal, Unip. Lda.
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
    • Poland (PL)
      Linezolid Accord
    • Spain (ES)
    • Germany (DE)
      Linezold Accord 2 mg/ml Infusionslösung
    • Denmark (DK)
    • Austria (AT)
    • Belgium (BE)
    • Ireland (IE)
    • Finland (FI)
    • France (FR)
    • Italy (IT)
    • Latvia (LV)
      Linezolid Accord 2 mg/ml šķīdums infūzijām
    • Norway (NO)
    • Sweden (SE)
    • Cyprus (CY)
      LINEZOLID ACCORD 2MG/ML SOL FOR INF
    • Czechia (CZ)
      Linezolid Accord 2 mg/ ml solution for infusion
    • Estonia (EE)
      LINEZOLID ACCORD
    • Croatia (HR)
    • Lithuania (LT)
      Linezolid Accord 2 mg/ml infuzinis tirpalas
    • Romania (RO)
      Linezolid Accord 2 mg/ml solutie perfuzabilã
    • Slovenia (SI)
    • Slovakia (SK)
许可日期2015/05/20
最近更新日期2023/04/20
药物ATC编码
    • J01XX08 linezolid
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase